Recent data released by the UK Health and Security Agency (UKHSA) indicates a decrease in meningitis cases one week after the outbreak commenced.
The latest statistics suggest a slowdown in the outbreak as a result of extensive efforts to administer vaccines and antibiotics to thousands of individuals in Kent, reducing the caseload to 29 under investigation by officials. This number is lower than the 34 cases reported by UKHSA on Saturday, returning to the level reported on Friday.
According to UKHSA, as of 12:30 pm on March 21, there are 20 confirmed laboratory cases and 9 cases still under investigation, totaling 29 cases. The agency noted a decrease of 3 confirmed cases compared to the previous day, with some cases being reclassified following additional laboratory tests and clinical examinations. It is anticipated that more probable cases will be downgraded in the upcoming days as further laboratory analyses are completed.
Tragically, two individuals have lost their lives, with no new fatalities reported since the last update. The data, collected as of 12:30 pm on Saturday, indicates that these cases have epidemiological links to Canterbury, Kent.
The figures include 20 laboratory-confirmed cases and 9 cases under investigation, reflecting a decrease of 3 confirmed cases since the Saturday report. UKHSA expressed gratitude to partners such as the NHS and the University of Kent for their swift assistance in providing vaccines and antibiotics in response to the outbreak.
Dr. Sherine Thomas, an Infectious Diseases Consultant at UKHSA, emphasized the agency’s commitment to staying vigilant for new cases while reassuring the public of the low overall risk. She highlighted the importance of recognizing symptoms of invasive meningococcal disease and seeking prompt medical attention if such symptoms arise.
UKHSA is collaborating with partners to identify contacts and offer necessary treatments. The decline in cases coincides with 8,002 individuals receiving vaccines and a total of 12,157 vaccine doses administered since the campaign’s inception.
Stay informed with daily updates on the latest news stories.